Amryt Pharma plc (LON:AMYT)’s share price traded up 1.6% during trading on Monday . The stock traded as high as GBX 170 ($2.22) and last traded at GBX 159 ($2.08). 266,723 shares changed hands during mid-day trading, an increase of 141% from the average session volume of 110,763 shares. The stock had previously closed at GBX 156.50 ($2.04).
Separately, Shore Capital restated a “house stock” rating on shares of Amryt Pharma in a research report on Thursday, June 3rd.
The company has a 50-day moving average price of GBX 164.85 and a 200 day moving average price of GBX 180.51. The firm has a market capitalization of £524.24 million and a PE ratio of -4.64. The company has a debt-to-equity ratio of 403.45, a current ratio of 2.19 and a quick ratio of 1.81.
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Featured Article: Dual Listing
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.